JAMES CRUMB: Open Payments
NPI 1265971097 · TRUSSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,786 in 109 payments from 19 companies in 2025. Trend: 2023 $2,451 · 2024 $2,049 · 2025 $1,786
Food & beverage: $1,786
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 24 | $340 |
| Amgen Inc. | 15 | $307 |
| Novo Nordisk Inc | 19 | $244 |
| GlaxoSmithKline, LLC. | 8 | $184 |
| ABBVIE INC. | 12 | $137 |
| Astellas Pharma US Inc | 5 | $94 |
| AstraZeneca Pharmaceuticals LP | 5 | $90 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $67 |
| Lilly USA, LLC | 3 | $53 |
| Axsome Therapeutics, Inc. | 2 | $45 |
Products named: NURTEC ODT, TRELEGY ELLIPTA, REPATHA, UBRELVY, Veozah, OTEZLA, Ozempic, JARDIANCE.
Industry payments across AL — which companies pay providers there.
